Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The Queen's University of Belfast has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 3 distinct art units, indicating a diverse range of pharmaceutical research. The use of 3 distinct art units for 3 pending office actions suggests that each filing covers a different technical niche within the biotechnology sector. This distribution requires practitioners to adapt to the specific standards of 3 separate departments.
Each pending action is assigned to a different official, resulting in 3 distinct examiners. HARRY RAYMOND BEHM is the busiest examiner with 1 pending office action. This structure means every active case is being handled by a unique examiner in a unique art unit. With 3 distinct examiners managing 3 pending office actions, the university faces a decentralized prosecution environment. Practitioners must develop 3 independent strategies to address the 3 pending office actions. The involvement of HARRY RAYMOND BEHM as the busiest examiner for 1 pending office action highlights the lack of examiner concentration in the current portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEHM, HARRY RAYMOND | 1 | 79.6% | +7.4% |
| PALENIK, JEFFREY T | 1 | 53.6% | +27.2% |
| MILLER, DALE R | 1 | 62.4% | +17.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18876519 | AC TO DC POWER CONVERSION METHOD AND SYSTEM | BEHM, HARRY RAYMOND | — |
| 18550874 | SUTURES | PALENIK, JEFFREY T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18550874 | SUTURES | PALENIK, JEFFREY T | — |
| 18034651 | IMMUNOMODULATORY AGENT | MILLER, DALE R | — |
| Art Unit | Apps |
|---|---|
| 2838 | 1 |
| 1615 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18876519 | AC TO DC POWER CONVERSION METHOD AND SYSTEM | BEHM, HARRY RAYMOND | 2838 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18550874 | SUTURES | PALENIK, JEFFREY T | 1615 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18034651 | IMMUNOMODULATORY AGENT | MILLER, DALE R | 1693 | §103DP | Final Rejection | — | Pending | Apr 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial